NCT00220168View on ClinicalTrials.gov

Phase II Trial Evaluating Irinotecan and Capecitabine Relapsed/Refractory Upper GI Tumours

PHASE4CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

January 31, 2003

Conditions
Upper Gastrointestinal Tumours
Interventions
DRUG

Irinotecan, Capecitabine

Trial Locations (1)

SM2 5PT

Royal Marsden Hospital, Sutton

All Listed Sponsors
lead

Royal Marsden NHS Foundation Trust

OTHER

NCT00220168 - Phase II Trial Evaluating Irinotecan and Capecitabine Relapsed/Refractory Upper GI Tumours | Biotech Hunter | Biotech Hunter